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Abstract Enzymatic activity and structure of N-terminus trun- 
cated and C-terminus substituted muscle acylphosphatase mu- 
tants were investigated by kinetic studies under different condi- 
tions and tH NMR spectroscopy, respectively. The N-terminus 
truncated mutant lacked the first six residues (A6), whereas 
arginine 97 and tyrosine 98 were replaced by glutamine giving two 
C-terminus substituted mutants (R97Q and Y98Q, respectively). 
All acylphosphatase forms were obtained by modifications of a 
synthetic gene coding for the human muscle enzyme which was 
expressed in E. coli. The A6 deletion mutant elicited a reduced 
specific activity and a native-like structure. The kinetic and struc- 
tural properties of R97Q and Y98Q mutants indicate a possible 
role of Arg-97 in the stabilisation of the active site correct confor- 
mation, most likely via back-bone and side chain interactions with 
Arg-23, the residue involved in phosphate binding by the enzyme. 
This study also suggests a possible involvement of Tyr-98 in the 
stabilisation of the acylphosphatase overall structure. 
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I. Introduction 
Acylphosphatase (acylphosphate phosphomonohydrolase, 
EC 3.6.1.7.) is a basic enzyme which catalyses the hydrolysis of 
acylphosphates both synthetic, such as benzoylphosphate [1], 
and of physiological interest, such as acetylphosphate, carbam- 
oylphosphate, succinylphosphate, 1,3-diphosphoglycerate, nd 
the phosphorylated intermediate formed during the activity of 
membrane pump ATPases [2-7]. Acylphosphatase is widely 
distributed in vertebrate tissues and organs as two isoenzymes 
displaying about 55% amino acid sequence homology. The 
genes for the two isoenzymes are probably originated by dupli- 
cation and evolution of a common ancestor [8]. The two isoen- 
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Abbreviations: Y98Q, tyrosine 98 to glutamine mutant; R97Q, arginine 
97 to glutamine mutant; d6, lacking residues 1-6 at the N-terminus; 
IPTG, isopropyl-thiogalactoside; CED-, cyanoethyldeoxy-; NMR, nu- 
clear magnetic resonance. 
zymes have been indicated as muscle and erythrocyte form, 
respectively, on the basis of the cell-type in which they predom- 
inate [9]. 
The primary structure of the two isoenzymes i olated from 
different species is known [10]. Basically, each isoenzyme con- 
sists of 98 amino acid residues, and can therefore be considered 
among the smallest enzymes known at present. The comparison 
of the amino acid sequences of the muscular isoenzymes from 
different species hows that this form is highly conserved, elic- 
iting only about 10% amino acid substitutions between mam- 
malian and avian species [10]. It has also been found that the 
NH2-terminus, which is always acetylated, is the most variable 
region of the enzyme. In some cases, the N-terminus contains 
additional residues, as it is found in the avian species, or is 
shorter, as in the rat enzyme [11]. 
The solution structure of the muscular isoenzyme has been 
determined by I H NMR spectroscopy and recently refined [12- 
15]. The enzyme consists of two interleaved packing units [16] 
with a quite uncommon folding pattern and chain topology, 
described only in few proteins uch as ferredoxin, the activation 
domain of procarboxypeptidase B, the RNA binding domain 
of the small nuclear ibonucleoprotein A [14,15] and a histidine 
containing phosphocarrier p otein [17]. The enzyme three-di- 
mensional structure agrees with the primary structure data, 
confirming the apparent reduced importance of the N-terminal 
region, that is not constrained in any persistent secondary 
structure and appears highly mobile. 
In spite of the large amounts of information available on the 
enzyme structure, little is known about he catalytic mechanism 
of both isoenzymes. In a study concerning the catalytic mecha- 
nism of the muscle enzyme [18], it was shown that a phosphate 
binding group with a pK a of about 11.0 is likely to participate 
to the catalytic ycle together with a group with a pK a of 7.9 
and, possibly, with an -OH group. Recently, it has been shown 
the participation of Arg-23 in substrate binding at the phos- 
phate level [19]. Previous data indicated that the two C-terminal 
residues of muscle acylphosphatase cannot be removed without 
loss of activity [20]. In fact, the Arg Tyr C-terminal dipeptide 
is part of a short fl-strand [14], and its removal is accompained 
by a complete loss of activity, whereas the removal of the 
C-terminal Tyr results in a remarkable reduction of the enzyme 
specific activity [20]. 
It appeared interesting to investigate the possibility of a re- 
duction in lenght of the enzyme at the N-terminus without loss 
of biological activity. We therefore prepared a muscle acyl- 
phosphatase derivative lacking the first six residues at the N- 
terminus by oligonucleotide-directed mutagenesis. We also 
studied two mutants containing the Arg-97 to Gln or Tyr-98 
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to Gin substitutions, respectively, to further elucidate the role 
of these residues in the enzyme activity. 
2. Materials and methods k 
2.1. Materials 
CNBr-activated Sepharose 4B was purchased from Pharmacia; ben- 
zoylphosphate was synthesized according to Camici et al. [21]. Specific 
polyclonal anti-horse muscle acylphosphatase ntibodies were obtained 
and purified according to Berti et al. [22]. [7-32p]ATP and [0~-nP]ATP 
(6000 Ci/mmol) were obtained from New England Nuclear. Horse- 
radish peroxidase-linked mouse anti-rabbit Ig was obtained from Bio- 
Rad. T4 DNA ligase, Klenow fragment of E. eoli DNA polymerase I, 
Taq polymerase and restriction enzyme NdeI were purchased from 
Polymed. Isopropyl-thiogalattoside (IPTG) was from Promega. USB- 
Sequenase was used for DNA sequencing, pT7.7 was a gift from Sclavo 
(Siena, Italy). The plasmid pTAP, containing a chemically synthesized 
polynucleotide s quence for human muscle acylphosphatase [23], was 
used for enzyme mutagenesis. Bacterial strain DH5 was used for prop- 
agation of the plasmid, and BL21 for deleted proteins expression. Ol- 
igonucleotides were synthesized using a Beckman system 200 A DNA 
synthesizer. Deuterium oxide and d;acetic acid were purchased from 
Merck. 
2.2. Enzyme xpression 
A6 deleted gene was obtained by polymerase chain reaction, whereas 
Tyr-98 mutant o Gin (Y98Q) and Arg-97 mutant o Gln (R97Q) were 
obtained by oligonucleotide-directed mutagenesis according to Mullis 
et al. [24]. A direct primer starting from the seventh codon was used 
to obtain the A6 deleted gene (Table 1). This primer, annealing to the 
synthetic gene coding for human muscle acylphosphatase [23], was 
designed in order to obtain a correct initiation codon for the transla- 
tion, after cDNA cloning in the pT7.7 plasmid. The T7 reverse primer 
annealing to pT7.7 region downstream the recombinant protein coding 
sequence was used for the amplification. Two reverse primers contain- 
ing the desired mutation, CGC (Arg) to CAA (Gln) and TAT (Tyr) to 
CAA (Gin) were used to construct the Arg-97 and Tyr-98 mutants, 
respectively (Table 1). For these amplifications, the T7 direct primer, 
annealing to the pT7.7 sequence before the NdeI restriction site, was 
used. All primers were synthesized using the CED-phosphoramidite 
method. 
The deleted gene A6 and the two R97Q and Y98Q mutant genes were 
Table 1 
Sequences of the oligonucleotides u ed for the production of the mu- 
tated enzymes 
Mutant Oligonuceotide s quence 
A6 5' TGAAGTCTGTCGATTACG 3' 
R97Q 5' AGCTTTAATA~'GAATAGAAAAG 3' 
Y98Q 5' AAGCTTTA~/~C.,GCGAATAGAAA 3' 
The oligonucleotides were synthesized using the CED-phosphoroamid- 
ite method on a Beckman system 200A DNA synthesizer. The triplettes 
corresponding to the mutated residues (CAA = Gin) are in bold. 
Table 2 
Main kinetic parameters of wild-type and mutated recombinant 
acylphosphatases 
Wild-type R97Q Y98Q A6 
Specific activity 7000 4700 3600 2500 
pH optimum 4.8-5.8 3.7~,.4 5.~5.9 4.7 5.9 
Kin* 0.51 1.14 0.41 0.55 
K~" 0.98 1.79 1.17 1.19 
The pH optimum was calculated at 25°C, in 0.1 M acetate buffer pH 
3.7-6.0 and in 50 mM 3,3-dimethylglutarate buffer pH 2.8-3.7 and 
6.(~7.5. The other parameters were determined at25°C in 0.1 M acetate 
buffer, pH 5.3 for all mutants, except R97Q which was assayed in the 
same buffer, pH 3.8. *Using benzoylphosphate s substrate. "For inor- 
ganic phosphate as competitive inhibitor. 
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Fig. 1. Western blot analysis of the wild-type, deleted, and mutated 
recombinant acylphosphatases. Lane A, molecular weight standards; 
lane B, wild-type; lane C, A6; lane D, R97Q; lane E, Y98Q. 
cloned separately in the NdeI single restriction site of the pT7.7 vector, 
treated with Klenow+ The recombinant clones were isolated by hy- 
bridisation. All mutants were confirmed by DNA sequencing according 
to Sanger et al. [25]. E. co/i strain BL21 was separately transformed with 
the modified sequences and the expression of the mutated proteins was 
obtained after induction with IPTG. Western blot analyses were per- 
formed according to Tsang et al. [26] using rabbit anti-recombinant 
human muscle acylphosphatase Ig and horseradish peroxidase-linked 
mouse anti-rabbit Ig as the second antibody. 
2.3. Enzyme purification and protein determination 
Recombinant wild-type and mutated acylphosphatases were purified 
by immunoaffinity chromatography using a column filled with an im- 
munoadsorbent prepared by linking purified specific anti-horse muscle 
acylphosphatase ntibodies, raised in rabbits, to a Sepharose 4B matrix, 
as previously reported [27]. The enzyme purity was assessed by amino 
acid analysis, reverse-phase chromatography, and SDS-PAGE. Protein 
concentration was measured by either amino acid analysis or ultraviolet 
1% - -  absorption at 280 nm; an Atcm.280 - 14.20 for both native and mutated 
acylphosphatases was used, except for the Y98Q mutant whose concen- 
tration was calculated only by amino acid analysis. Amino acid analyses 
were performed using a Carlo Erba mod. 3A29 amino acid analyzer 
equipped with a Spectra Physics SP4100 computing integrator, as pre- 
viously described [28]. Values for serine and threonine were corrected 
as for degradation by extrapolation to zero hydrolysis time. 
2.4. Enzyme activity measurements 
Native and mutated acylphosphatase activities were determined 
using benzoylphosphate s a substrate as previously described [29]. The 
urea used in the inactivation experiments was previously deionised by 
treatment with an AG501X8 ion exchange resin (Bio-Rad). 
2.5. IH NMR analysis 
The A6, R97Q and Y98Q samples were prepared by five dilution/ 
concentration cycles in 50 mM d3-acetate/D20 buffer at pH 3.8 using 
Centricon-3 microconcentrators (Amicon). pH electrode readings were 
not corrected for isotope effect. The protein concentration was about 
0.5 mM in all samples. One-dimensional ~H NMR experiments were 
performed at 600 MHz on a AMX600 Bruker NMR spectrometer, at 
30°C. The spectra were acquired using a sweep width of 7246 Hz and 
16384 data points. The residual water signal was suppressed by low 
power irradiation during the relaxation delay (1.0 s). Prior to Fourier 
transformation, the free induction decays were zero-filled to 32768 data 
points and multiplied by a resolution-enhancing Gaussian function 
(with the maximum of the Gaussian set to 0.1 and a line broadening 
factor o f -2  Hz). 1,4-dioxane was used as an internal shift reference at 
3.74 ppm. 
3. Results 
A deleted synthetic gene for acylphosphatase, lacking the 
first six amino acids from the protein N-terminus (mutant A6) 
was prepared together with two mutated genes where the Arg- 
N. Taddei et al./FEBS Letters 362 (1995) 175-179 177 
c- 
o 
lb. 
CL 
C~ 
E 
m 
5 
8000 
6000 
4000 
2000 
200 " 
(~ O ,~ 150- 
0 0 
O 100, 
• O 50 '  
O 
O 
i I I ' ' * "  • 
I l i ;n l J l t , |  i 
• x • 
• 0 i 
• • • [UREA] 
0 
X x X x X X 
Z~ ~ A 
XX 
X 
X 
X 
A 
A 
X 
X 
I I I I I I 
0 1 2 3 4 5 6 7 8 
[UREA] 
Fig. 2. Plot of the specific activity of recombinant muscle acylphosphatases vs. urea concentration at pH 5.3 and 25 °C. o: wild-type; e: R97Q mutant; 
x: Y98Q mutant; A: A6 deleted mutant. Inset: same data expressed as % activity, where 100% is the activity of the single species in the absence of 
urea. 
97 and Tyr-98 codons were replaced by those for Gin (mutants 
R97Q and Y98Q, respectively). All genes were inserted into the 
E. coli expression vector pT7.7 and amplified in E. coli strain 
DH5. E. coli strain BL21 was transformed with the recombi- 
nant plasmids (pAP A6, pAP R97Q, pAP Y98Q) and supple- 
mented with 0.5 mM IPTG to induce recombinant protein 
expression. The bacterial cells were lysated by sonication, the 
proteins present in the supernatant separated by 15% SDS- 
PAGE and subjected to Western blot analysis using polyclonal 
anti-recombinant muscle acylphosphatase antibodies (Fig. 1). 
Four bands were present, corresponding to the wild-type acyl- 
phosphatase and to the mutated proteins; a negative control 
was also prepared consisting of the strain BL21 trasformed with 
the pT7.7 without the insert (data not shown). The mutant 
acylphosphatases present in the lysates were purified as de- 
scribed in section 2. The purified mutant acylphosphatases were 
characterised as for kinetic properties, stability, and structure. 
Table 2 reports the main kinetic parameters of the mutant 
enzymes. All acylphosphatase mutants elicited specific activity 
values ranging from 35% to 66% with respect o the wild-type 
enzyme. All mutants and wild-type recombinant 
acylphosphatases showed apparent K m values very similar to 
each other; the R97Q mutant pH-optimum was slightly shifted 
towards acidity. 
The urea denaturation of the mutated and wild-type 
acylphosphatases was studied at both pH 5.3 and pH 3.8. The 
activities of all urea-inactivated enzymes were almost com- 
pletely restored when measured in the absence of urea; this 
behaviour agrees with that of the non-recombinant muscular 
isoenzyme [30,31]. Fig. 2 shows the urea dependence of the 
inactivation of the wild-type and mutated enzymes in 0.1 M 
acetate buffer at pH 5.3 and 25 °C. It can be seen that the A6 
mutant behaves quite similarly to the wild-type recombinant 
enzyme. The urea concentration at which these forms are 50% 
inactivated (inactivation midpoint) is about 4.2 M. The Y98Q 
mutant appeared slightly more sensitive to urea, showing an 
inactivation midpoint at 3.8 M. Instead, at low urea concentra- 
tions, the R97Q mutant showed a sharp activation which 
reached a maximum (about 50%) at 3 M urea, followed by a 
rapid inactivation leaving 20% active, and completely inactive 
enzyme at 6 M and 8 M urea, respectively. The specific activity 
of the R97Q mutant in the presence of 3 M urea was nearly the 
same as compared to that of the wild-type enzyme under the 
same conditions (Fig. 2). Similar inactivation experiments were 
carried out in 50 mM acetate buffer, pH 3.8, both at 25 and 37 
°C. The results of such inactivation studies are summarised in 
Table 3. 
'H NMR spectra were recorded to assess possible changes 
Table 3 
Urea inactivation experiments of wild-type and mutated acylphosphatases 
pH 5.3, 25°C pH 3.8, 25°C pH 3.8, 37°C 
Cm Activation c m Activation c m Activation 
Wild-type 4.2 M No 2.6 M No 2.0 M No 
R97Q 5.2 M 50%, 3 M 3.0 M 25%, 1.5 M 2.5 M No* 
Y98Q 3.8 M No 2.6 M No 2.0 M No 
A6 4.2 M No 2.6 M No 2.0 M No 
The enzymes were pre-incubated for 60 min and subsequently assayed in 50 mM acetate buffer, in the presence of urea concentrations ranging between 
0 and 8 M. Cm is the urea concentration required to reduce the enzyme activity to 50% of the value calculated in the absence of urea. Activation, 
where present, is expressed as % of the enzymatic activity in the absence of urea. The urea concentration atwhich the activation ismaximum is also 
reported. *Under this condition there is no activation, however, the R97Q mutant maintains the initial activity up to 1.5 M urea, 
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Fig. 3. Aromatic and aliphatic regions of the 600 MHz 1H NMR spectra 
of recombinant acylphosphatases. The samples were in 50 mM d3- 
acetate buffer/D20, pH 3.8 at 30 °C. A: wild-type recombinant enzyme; 
B: A6 deleted acylphosphatase; C: R97Q mutant; D: Y98Q mutant. 
in the fold of the different acylphosphatase forms. Fig. 3 shows 
the aliphatic and aromatic proton regions of the 600 MHz ~H 
NMR spectra of all investigated nzymes. A remarkable chem- 
ical shift dispersion is characteristic of a protein with a well- 
constrained fold, i.e. a native, biologically active protein. A 
recent study demostrated that the 1H NMR spectrum of the 
wild-type recombinant acylphosphatase i  very similar to that 
of the non-recombinant enzyme [23], confirming a high degree 
of  structural homology between these forms. As can be ob- 
served in Fig. 3, the IH NMR spectra of the A6 and R97Q 
mutants how a chemical shift dispersion closely resembling 
that found in the spectrum of the wild-type recombinant en- 
zyme. Only minor changes in chemical shift of both aromatic 
and aliphatic resonances are evident from these one-dimen- 
sional spectra. The Y98Q mutant 1H NMR spectrum, though 
maintaining the overall chemical shift dispersion, shows some 
resonances characteristic of the random-coil conformation 
[31,32], in particular the methyl proton and the tyrosine 3,5 ring 
protons peaks at about 1.0 and 6.8 ppm, respectively, are pres- 
ent. Moreover, in the same spectrum, the intensity of the ali- 
phatic resonances below 0.6 ppm, characteristic of the native 
fold, are considerably reduced. 
4. Discussion 
The A6, R97Q and Y98Q mutated acylphosphatases tudied 
in this paper elicit a reduced specific activity with respect to the 
wild-type recombinant enzyme, whereas the apparent Km value 
is nearly identical. This data is confirmed by the IH NMR 
spectra of all enzyme forms. As far as the/16 deletion mutant 
is concerned, it has previously been reported that the 1-6 seg- 
ment is highly mobile and apparently not involved in the forma- 
tion of any secondary structure lement [16]. Nevertheless, the 
sharp reduction of the specific activity of this mutant, indicates 
that the removal of the 1-6 segment somewhat affects the active 
site structure. The tH NMR spectrum of this mutant shows the 
absence of any major conformational change, indicating that 
the loss of catalytic activity is probably due to minor local 
structural modifications at the active site that do not affect the 
substrate binding. 
The R97Q and Y98Q mutants possess specific activities 
which are about 66% and 50% that of the wild type recombi- 
nant enzyme, respectively. The R97Q ~H NMR spectrum is 
similar to that of the wild-type recombinant enzyme, indicating 
that the overall folds of the two enzymes are basically identical. 
Instead, the Y98Q ~H NMR spectrum shows the presence of 
intense resonances, characteristic of the denatured acyl- 
phosphatase [19,31], that are not present in the wild-type en- 
zyme spectrum. A partial oss of tertiary structure of this mu- 
tant could explain the appearance of these peaks and the con- 
comitant reduction in intensity of the resonances below 0.6 
ppm. In the light of these structural findings, the reduced spe- 
cific activities of both mutants could be ascribed to different 
effects of the residue replacements. Tyr-98 appears a critical 
residue for the maintainance of the fully native-like structure 
whereas the R97Q reduced specific activity might be due to a 
local effect on the active site stability. Nevertheless, these resi- 
dues are not likely to affect substrate binding site structure, in 
view of the identity of the apparent Km value. In a previous 
paper, it was shown that the enzyme derivative lacking the 
Arg-97 Tyr-98 C-terminal dipeptide was completely inactive 
though apparently eliciting a global native-like fold [20]. These 
results led to hypothesize that Arg-97 could be involved in the 
enzyme catalytic mechanism. However, our data demonstrates 
that the Arg-97 mutation is not accompained by a complete loss 
of enzymatic activity. This apparent contradiction can be ex- 
plained assuming that the removal of the C-terminal dipeptide 
destabilises the active site structure. In fact, this dipeptide is 
part of the fifth fl-strand, forming an hydrogen bonding net- 
work to other secondary structure lements [14]. The simple 
mutation of the Arg-97 residue does not seem severe enough 
to determine the same effects of the C-terminal dipeptide dele- 
tion. 
The results of the urea inactivation experiments show that 
the A6 deletion mutant and the Y98Q mutant behave similarly 
to the wild-type recombinant enzyme both at pH 5.3 and pH 
3.8. However, all three forms are less stable when compared 
with the native horse muscle nzyme [31]. This difference could 
be explained by considering that the recombinant and native 
acylphosphatases were from different species (human and 
horse, respectively) and, more important, hat the recombinant 
enzymes are not acetylated at the N-terminus. The R97Q mu- 
tant shows a peculiar behaviour appearing activated up to 1.5 
M and 3 M urea, at pH 3.8 and 5.3, respectively. The activation 
is such that the specific activity of this mutant becomes very 
similar to that of the wild-type recombinant enzyme, when 
measured under the same conditions. Thus, in the presence of 
urea, the enzyme activity appears no longer affected by the 
arginine substitution. This finding could be explained by the 
existence of a persistent interaction between urea and the Gln- 
97 side-chain; the urea-Gin-97 complex would be able to mimic 
the interactions of Arg-97 to other parts of the molecule stabil- 
ising the correct enzyme conformation at the active site, and 
favouring enzyme catalysis. A recent refinement of the acyl- 
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phosphatase solution structure revealed that the Arg-97 side- 
chain interacts with other residues (A. Pastore, personal com- 
munication), in particular with Arg-23, whose side-chain par- 
ticipates to the substrate binding site [19]. The structural and 
physico-chemical features of such an Arg-Arg interaction in 
proteins have recently been investigated [33]. The absence of 
urea activation in the Y98Q mutant, indicates that this effect 
is specific for Arg-97. 
The reported results suggest that Arg-97 and Tyr-98 are not 
directly involved in the acyl-phosphatase catalytic mechanism 
or substrate binding. Instead, these residues appear involved in 
the stabilisation of the active site (Arg-97) and of the protein 
global conformation (Tyr-98). The contribution to this stabili- 
sation by each residue is limited, as demostrated by the specific 
activity value of the two mutants and of the enzyme lacking 
Tyr-98 [20]. However, the sum of these contributions appears 
essential for enzyme activity, as suggested by the complete 
enzyme inactivation following the removal of the C-terminal 
dipeptide [20]. Our data indicate that acylphosphatase cannot 
be shortened either at the N- and C-terminus without partial 
or complete loss of activity, though the C-terminal region ap- 
pears more important for the maintainance of the correct fold 
of the enzyme. 
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